Navigation Links
CalbaTech, Inc. Officially Changes Name to LifeStem International, Inc.; Lists New Symbol (LSTM) and Launches New Web Site
Date:5/1/2008

LAGUNA HILLS, Calif., May 1 /PRNewswire-FirstCall/ -- LifeStem International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, Inc. (OTC Bulletin Board: CLBE), the emerging life sciences company concentrating on the collection and banking of adult stem cells for possible future therapeutic uses, today announced that as of May 2, it will have officially changed its name, obtained a new trading symbol, effected a 3000 for 1 reverse stock split, and launched its new website at http://www.lifesteminternational.com.

The new web site gives significant background on the Company's proprietary Stem Cell MicroBank(TM), its unique method of stem cell banking that allows healthy individuals to collect and store their stem cells for possible future therapeutic use. The web site also explains the Company's Research Reagents Division, which includes K-D Medical, Inc. and MoleculA, Inc. in Columbia, Maryland. Also included on the site is information for the investor on our financial filings and news releases, as well as information on management and the scientific advisory board.

LifeStem's Stem Cell MicroBank(TM) Service is a process that involves the harvesting of adult stem cells in micro quantities from both blood and adipose tissue. The cells are then cryopreserved for future possible therapeutic applications and therapies, such as grafting new skin cells for burn victims, regenerating corneas and producing and regulating insulin for diabetics.

About LifeStem International, Inc.

LifeStem International, Inc. (OTC Bulletin Board: LSTM) is the emerging life sciences company (http://www.lifesteminternational.com), concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells.

Note: Certain statements in this news release may contain "forward-looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to being in a large and growing market, exhibiting rapid growth characteristics, and having a growth strategy, are forward-looking statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or assumptions in this press release include the risk that we will not be able to grow our revenues and market share, the risk that our prices do not remain competitive and the risk that we will not achieve profitability. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

Contact: Paul Knopick

E & E Communications

949/707-5365

pknopick@eandecommunications.com


'/>"/>
SOURCE LifeStem International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. Albertsons Officially Launches Healthy Eaters(TM) Field Trip Program
3. University Hospital of Bordeaux Officially Opens New Electrophysiology Lab
4. Hooray for the Bay! San Francisco Officially Named Best Place to Leave Your Heart...and Keep Your Health
5. Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company
6. CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville
7. Genetic Changes May Dictate Course of Acute Myeloid Leukemia
8. GSK Announces Changes to Corporate Executive Team
9. Changes to Family and Medical Leave Act Clarify Employer Responsibilities
10. Procter & Gamble Announces Board Changes
11. Physicians Anticipate Changes in Their Usage of Hip Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: